.svg){kind=icon}
THC is the cannabis compound most closely associated with intoxication—but the reason THC produces psychoactive effects begins inside the human body.
The brain contains proteins known as CB1 cannabinoid receptors. These receptors are part of the endocannabinoid system, a signaling network that normally responds to naturally produced molecules such as anandamide and 2-AG.
THC is able to interact with many of those same receptors.
When THC reaches the brain and activates CB1 receptors, it can change communication between neurons. Depending on dose, route, tolerance, and individual biology, those changes can influence memory, perception, appetite, mood, coordination, concentration, and the sense of time.
Understanding this relationship helps explain why THC can produce both desired and unwanted effects—and why higher potency does not automatically mean better medical cannabis outcomes.
What Is THC?
THC stands for delta-9-tetrahydrocannabinol.
It is a phytocannabinoid produced by the cannabis plant and is primarily responsible for the familiar intoxicating effects associated with cannabis.
Raw cannabis contains substantial amounts of THCA, or tetrahydrocannabinolic acid. Heating cannabis through smoking, vaporization, or processing converts some THCA into THC through a process called decarboxylation.
Once THC enters the bloodstream, it can travel throughout the body and cross into the brain.
There, CB1 receptors become particularly important.
What Are CB1 Receptors?
CB1 receptors are part of the endocannabinoid system.
They belong to a large family of signaling proteins known as G-protein-coupled receptors, or GPCRs.
CB1 receptors are especially abundant throughout the brain and central nervous system.
Important areas containing substantial CB1 activity include the:
- Hippocampus
- Cerebral cortex
- Basal ganglia
- Cerebellum
- Amygdala
- Reward-related brain circuits
These regions help regulate memory, learning, movement, emotional responses, motivation, perception, and other neurological functions.
That distribution helps explain why one cannabinoid can produce several effects at the same time.
THC Acts as a Partial Agonist
THC does not merely attach to CB1 receptors.
It acts as a partial agonist.
An agonist is a molecule that binds to a receptor and activates it. A partial agonist activates the receptor but does not necessarily produce the maximum signaling response possible at that receptor.
This is an important distinction.
CB1 signaling is not simply:
OFF → THC arrives → ON
Instead, the strength and character of the response depend on several factors, including:
- THC concentration
- Amount consumed
- Receptor location
- Frequency of use
- Individual tolerance
- Route of administration
- Other cannabinoids
- Individual physiology
This is why two patients can use the same THC product and experience substantially different effects.
What Happens After THC Activates CB1?
When THC activates a CB1 receptor, the receptor changes intracellular signaling.
CB1 signaling can influence the release of neurotransmitters between neurons.
In simplified terms, activation can reduce the release of certain chemical messengers from nerve cells.
That alters communication within the neural circuit where those receptors are located.
The outcome depends heavily on the brain region involved.
CB1 activation in a memory-related circuit may influence short-term memory.
CB1 activity in motor-control regions may affect coordination.
Activation in appetite-related pathways may influence hunger.
The same THC molecule can therefore participate in several effects because CB1 receptors are distributed across many different neural networks.
Why THC Can Affect Short-Term Memory
The hippocampus is heavily involved in forming and organizing memories.
It also contains substantial CB1 receptor activity.
When THC changes cannabinoid signaling within hippocampal circuits, short-term memory and the ability to process new information may become temporarily impaired.
Patients may experience difficulty remembering what was just discussed or maintaining focus on a complicated task.
This effect does not mean CB1 receptors normally exist to disrupt memory.
The body's own endocannabinoids use CB1 signaling as part of normal neural regulation.
THC enters that existing system from outside the body and can activate receptors more broadly or for longer periods.
Why Coordination Can Change
The cerebellum and basal ganglia both participate in movement and coordination.
Both contain CB1 receptors.
THC activity in these pathways can contribute to:
- Slower reaction time
- Altered balance
- Reduced coordination
- Changes in motor control
This is one reason THC impairment and driving do not mix.
Even when a patient feels subjectively comfortable, neurological processes involved in reaction time, attention, and motor control may still be affected.
Why Time and Perception Can Feel Different
CB1 receptors are also found throughout cortical and sensory-processing networks.
THC can alter the way these neural systems process incoming information.
Some people report that time seems to pass more slowly, sounds or visual sensations feel different, or ordinary experiences become unusually noticeable.
These are psychoactive effects because THC is changing how the brain processes information.
The intensity can vary significantly according to dose and previous cannabis experience.
Why THC Can Increase Appetite
CB1 signaling also participates in appetite and reward pathways.
THC's activation of these receptors can influence hunger signals and the perceived reward associated with food.
This contributes to the well-known appetite increase sometimes associated with cannabis.
Again, receptor biology is only part of the picture.
Appetite is influenced by hormones, metabolism, gastrointestinal signaling, blood sugar, psychological factors, and many other systems.
Why Higher Doses Can Feel Very Different
THC has a dose-dependent effect.
Increasing the amount does not simply create a stronger version of the same experience.
At lower exposure, some patients may describe relaxation or relatively subtle changes.
At higher exposure, the same person may experience:
- Anxiety
- Panic
- Dizziness
- Rapid heart rate
- Significant sedation
- Memory impairment
- Poor coordination
- Paranoia
- Uncomfortable intoxication
This is why THC percentage should not be used as a simple measure of product quality.
A higher-potency product can make it easier to consume more THC in a shorter period.
Inhaled THC vs. Oral THC
Administration route significantly affects the psychoactive experience.
Inhaled THC
Smoking or vaporization generally delivers THC into circulation relatively quickly.
Effects may begin within minutes, which can make changes in perception and cognition noticeable soon after administration.
Oral THC
Edibles follow a different pathway.
THC passes through the gastrointestinal system and liver before reaching systemic circulation.
During liver metabolism, some THC is converted into 11-hydroxy-THC, an active metabolite capable of entering the brain.
This contributes to the delayed onset and often longer-lasting effects associated with oral cannabis.
The delayed onset also creates a practical risk: taking additional THC before the first dose has fully developed.
Why THC Tolerance Develops
Repeated CB1 activation can cause the nervous system to adapt.
With frequent THC exposure, CB1 receptors may become less responsive through processes including receptor desensitization and changes in receptor availability.
The result can be tolerance.
A patient may notice that the amount once producing a strong effect becomes less noticeable over time.
Increasing the dose automatically is not always the best response.
Growing tolerance can be a reason to reassess frequency, dose, treatment goals, and overall response with a qualified physician.
THC Is Different From Anandamide
Anandamide is one of the body's natural endocannabinoids.
Both anandamide and THC can activate CB1 receptors, but their signaling behavior is different.
Anandamide is generally produced on demand and rapidly broken down, primarily through the enzyme FAAH.
THC comes from outside the body and follows different absorption, distribution, and metabolic pathways.
Cannabis therefore does not simply “replace” anandamide.
THC interacts with a biological signaling system that was already operating.
THC Is Also Different From 2-AG
2-AG is another major endocannabinoid.
It can activate both CB1 and CB2 receptors and plays a major role in retrograde signaling between neurons.
The body produces 2-AG locally and breaks it down largely through the enzyme MAGL.
Again, THC can influence some of the same receptors, but externally administered THC does not reproduce 2-AG signaling exactly.
This distinction matters when explaining cannabis pharmacology.
Does CBD Stop THC From Binding CB1?
CBD does not work as a simple CB1 blocker.
It has relatively little direct activity at the primary CB1 binding site compared with THC and influences several other biological targets.
Researchers have investigated CBD as an allosteric modulator of CB1 signaling, meaning it may influence how the receptor responds without interacting in exactly the same way as THC.
However, the interaction between THC and CBD is complex.
Patients should not assume that adding CBD will reliably cancel excessive THC intoxication.
What About Cannabis Terpenes?
Terpenes such as myrcene, limonene, pinene, linalool, humulene, and beta-caryophyllene contribute to the chemical profile of cannabis.
They are not THC and generally do not activate CB1 receptors in the same way.
Beta-caryophyllene is particularly interesting because it can interact with CB2 receptors.
Research into cannabinoid-terpene combinations continues, but terpene profiles cannot reliably predict the intensity of THC intoxication.
THC dose remains a major driver of CB1-related psychoactive effects.
Green Dragon Florida Products as THC Examples
The following products illustrate how THC concentration and administration route can change cannabinoid exposure. They are not recommendations for producing stronger psychoactive effects or treating a specific condition.
Green Dragon Tangie Candie Flower — Tampa
Green Dragon Tangie Candie Flower is a 3.5-gram hybrid flower currently listed at approximately 21.4% THC and 1.28% total terpenes.
Flower provides relatively rapid THC exposure when inhaled, but the amount reaching CB1 receptors depends on how much is used and the patient's inhalation technique.
Magnus SR Tangie Cartridge — Jacksonville 103rd
Magnus SR Tangie Cartridge is a one-gram vaporizer cartridge currently listed at approximately 88.2% THC and 2.89% total terpenes.
Its concentrated THC content illustrates why potency matters. Relatively little vaporized material may provide a substantial THC dose compared with flower.
PLUS Raspberry Chews — Fort Myers
PLUS Raspberry Chews contain 100 mg of total THC per package.
Oral THC reaches CB1 signaling through a different pharmacokinetic pathway than inhaled cannabis. Delayed onset and formation of 11-hydroxy-THC make careful attention to individual serving size especially important.
Availability, potency, terpene profiles, and laboratory information may change by Green Dragon Florida location and batch.
The Green Dragon Takeaway
THC produces psychoactive effects largely because it can enter the brain and activate CB1 cannabinoid receptors.
Those receptors are distributed throughout neural systems involved in memory, coordination, appetite, perception, emotion, movement, and reward.
THC does not activate every CB1 receptor equally, and the experience is influenced by dose, route, metabolism, tolerance, product potency, and individual biology.
That explains an important medical cannabis principle:
More THC does not automatically mean a better outcome.
Understanding CB1 pharmacology helps patients look beyond THC percentage and think instead about measured dosing, administration route, response, and unwanted effects.